Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Collet

Showing results (341-350 of 376) with videos related to

Pageof 38
Sort By:
European Heart Journal|September 1, 2014
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Stephan Windecker, Philippe Kolh, et al.
JACC. Cardiovascular Interventions|March 9, 2016
Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ AnalysisGilles Montalescot, Arnoud W van 't Hof, Leonardo Bolognese, et al.
Revista Espanola De Cardiologia (English Ed.)|January 28, 2015
2014 ESC/EACTS guidelines on myocardial revascularizationStephanWindecker, Philippe Kolh, Fernando Alfonso, et al.
The Canadian Journal of Cardiology|February 28, 2026
Definition and prediction of periprocedural myocardial infarction in elective percutaneous coronary intervention: the ALPHEUS-MI studyMichel Zeitouni, Gilles Montalescot, Vincent Roule, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 5, 2014
2014 ESC/EACTS guidelines on myocardial revascularizationStephan Windecker, Philippe Kolh, Fernando Alfonso, et al.
Circulation|April 11, 2014
High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC studyGilles Montalescot, Grégoire Rangé, Johanne Silvain, et al.
European Heart Journal|August 30, 2020
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular diseaseAntonio Pelliccia, Sanjay Sharma, Sabiha Gati, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 25, 2018
Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-MorphineFrédéric Lapostolle, Arnoud W Van't Hof, Christian W Hamm, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2022
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registryJoseph Nowatzke, Paul Guedeney, Nicholas Palaskas, et al.
Nature Reviews. Cardiology|June 13, 2022
P2Y<sub>12</sub> inhibitor monotherapy in patients undergoing percutaneous coronary interventionDavide Capodanno, Usman Baber, Deepak L Bhatt, et al.
Pageof 38

Showing results (341-350 of 376) with videos related to

Sort By:
Pageof 38
European Heart Journal|September 1, 2014
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Stephan Windecker, Philippe Kolh, et al.
JACC. Cardiovascular Interventions|March 9, 2016
Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ AnalysisGilles Montalescot, Arnoud W van 't Hof, Leonardo Bolognese, et al.
Revista Espanola De Cardiologia (English Ed.)|January 28, 2015
2014 ESC/EACTS guidelines on myocardial revascularizationStephanWindecker, Philippe Kolh, Fernando Alfonso, et al.
The Canadian Journal of Cardiology|February 28, 2026
Definition and prediction of periprocedural myocardial infarction in elective percutaneous coronary intervention: the ALPHEUS-MI studyMichel Zeitouni, Gilles Montalescot, Vincent Roule, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 5, 2014
2014 ESC/EACTS guidelines on myocardial revascularizationStephan Windecker, Philippe Kolh, Fernando Alfonso, et al.
Circulation|April 11, 2014
High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC studyGilles Montalescot, Grégoire Rangé, Johanne Silvain, et al.
European Heart Journal|August 30, 2020
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular diseaseAntonio Pelliccia, Sanjay Sharma, Sabiha Gati, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 25, 2018
Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-MorphineFrédéric Lapostolle, Arnoud W Van't Hof, Christian W Hamm, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2022
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registryJoseph Nowatzke, Paul Guedeney, Nicholas Palaskas, et al.
Nature Reviews. Cardiology|June 13, 2022
P2Y<sub>12</sub> inhibitor monotherapy in patients undergoing percutaneous coronary interventionDavide Capodanno, Usman Baber, Deepak L Bhatt, et al.
Pageof 38